Search for: "Shire Development Inc."
Results 21 - 40
of 47
Sorted by Relevance
|
Sort by Date
12 Sep 2011, 6:18 am
Shire asserted that Mickle breached all these provisions by developing new intellectual property based on the assigned patents after he left NRP and by assigning his interests in those new patents to KemPharm, his new company, rather than to NRP. [read post]
31 May 2012, 7:50 am
Atwood Mobile Products, LLC US7248156 “LP & CO Gas Detectors” 2:12-cv-03234 New Jersey District Court … [read post]
8 Jul 2016, 4:00 am
” (Shire Canada Inc. v. [read post]
14 Apr 2009, 5:20 am
Shire United States, Inc., CA NO. 08-941 2009 U.S. [read post]
1 Oct 2020, 10:46 am
Shire ViroPharma, Inc. in which the court held that the FTC must plead facts sufficient to show that a defendant “is” or “is about to” violate the law in order to proceed under Section 13(b). [read post]
5 May 2010, 4:46 am
Impax Laboratories Inc. [read post]
1 Dec 2017, 11:35 am
China’s Sanpower Group Co., Ltd. acquired Dendreon Pharmaceuticals Inc for $0.8 billion, and Sumitomo Dainippon Pharma Co., Ltd. acquired Tolero Pharmaceuticals Inc. for $0.8 billion to assist Sumitomo to refresh its pipeline.[28] In Q4 2017, a few M&A transactions have occurred in the pharma deal market. [read post]
10 Jun 2010, 3:58 am
Actavis Inc. et al. [read post]
17 Jul 2017, 4:20 pm
Shire Development LLC v. [read post]
14 Jul 2010, 6:47 pm
(Patent Docs) Lialda (Mesalazine /Mesalamine) – US: Patent infringement complaint following Paragraph IV certification: Shire Development Inc. et al. v. [read post]
29 Mar 2010, 5:00 am
Shire, Inc., 2010 WL 937279 (Pa. [read post]
3 Dec 2021, 6:06 am
, Proxy advisors, Proxy voting, Say on climate, Shareholder voting Important Earnout/Milestone Drafting Points Arising from Recent Pacira and Shire Decisions Posted by Gail Weinstein, Brian T. [read post]
22 Jul 2011, 9:14 am
Andrews DeTect, Inc. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
12 Mar 2020, 6:49 am
The book initially sold for $150, then $250.As for Agora, it developed the idea of using “Congressional Checks” as a metaphor for the anticipated tax-advantaged treatment of certain pass-through dividend income that would result from the 2017 Tax Cuts and Jobs Act (“TCJA”) passed by the Republican Congress in 2017. [read post]
16 Sep 2009, 1:47 pm
(Allston, MA; Tae Yi, President) Black Trace, Inc. [read post]
26 Dec 2017, 7:08 pm
Shire Pharmaceuticals LLC paid $350 million to resolve allegations that Shire and the company it acquired in 2011, Advanced BioHealing (ABH), induced clinics and physicians to use or overuse its bioengineered human skin substitute by offering lavish dinners, drinks, entertainment and travel; medical equipment and supplies; unwarranted payments for purported speaking engagements and bogus case studies; and cash, credits and rebates. [read post]
26 Jun 2017, 1:00 am
Aberdeen City and Shire Strategic Development Planning Authority v Elsick Development Company Ltd (Scotland), heard 13 Jun 2017. [read post]
6 Apr 2011, 12:18 am
General The Hinxton Group foresees stem cell issues and proposes solutions (Patent Docs) FAO Seed Treaty carries hope, addressing country contributions, farmers concerns (IP Watch) Australia provides for developing countries in need of pharmaceuticals (IP Whiteboard) Belgium: Supreme Court upholds confidentiality measures in Novartis v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
